YOUR FRIENDS' ACTIVITY

    Biotech News Headlines

    • A mosquito is prepared to be studied in a laboratory
      Two gene clues for resistance to malaria AFP - 16 hrs ago

      Scientists in Germany and Africa on Wednesday said they had found two variants of genes that help to explain why some lucky individuals do not develop severe malaria … More »Two gene clues for resistance to malaria

      A mosquito is prepared to be studied in a laboratory

      Scientists in Germany and Africa on Wednesday said they had found two variants of genes that help to explain why some lucky individuals do not develop severe malaria.

    • Agribusinesses focus on farm policy, biotechnology AP - Tue, Aug 14, 2012

      Biotechnology and U.S. farm policy will be the focus of an upcoming conference of the Kansas Agribusiness Retailers Association. More »Agribusinesses focus on farm policy, biotechnology

      Biotechnology and U.S. farm policy will be the focus of an upcoming conference of the Kansas Agribusiness Retailers Association.

    • Genetic Research Sheds Light on Jewish Diaspora HealthDay - Wed, Aug 8, 2012

      TUESDAY, Aug. 7 (HealthDay News) -- A new genetic analysis of Jews from North Africa provides evidence that Middle Eastern Jews settled in the region during Classical … More »Genetic Research Sheds Light on Jewish Diaspora

      TUESDAY, Aug. 7 (HealthDay News) -- A new genetic analysis of Jews from North Africa provides evidence that Middle Eastern Jews settled in the region during Classical Antiquity, married local populations and formed distinct populations that remained largely intact for more than 2,000 years.

    • Study Uses Stem Cells to Boost Red Blood Cell Production HealthDay - Wed, Aug 8, 2012

      TUESDAY, Aug. 7 (HealthDay News) -- Using human stem cells, scientists have developed methods to boost the production of red blood cells, according to a new study. More »Study Uses Stem Cells to Boost Red Blood Cell Production

      TUESDAY, Aug. 7 (HealthDay News) -- Using human stem cells, scientists have developed methods to boost the production of red blood cells, according to a new study.

    • Johns Hopkins University scientists Se-Jun Lee (L) and Alexandra McPherron (R) look at a normal mouse and a genetically-engineered mouse (R) that is two to three times more muscular than the normal mouse in this undated handout photo
      Testers fear reality of genetically modified Olympians Kate Kelland - Reuters - Tue, Aug 7, 2012

      LONDON (Reuters) - There have been "marathon mice", "Schwarzenegger mice" and dogs whose wasted muscles were repaired with injected substances that switch off key genes. … More »Testers fear reality of genetically modified Olympians

      Johns Hopkins University scientists Se-Jun Lee (L) and Alexandra McPherron (R) look at a normal mouse and a genetically-engineered mouse (R) that is two to three times more muscular than the normal mouse in this undated handout photo

      LONDON (Reuters) - There have been "marathon mice", "Schwarzenegger mice" and dogs whose wasted muscles were repaired with injected substances that switch off key genes. It may not be long before we get the first genetically modified athlete. Some fear the use of gene therapy to improve athleticism is already a reality. …

    • FEATURE-Testers fear reality of genetically modified Olympians Kate Kelland - Reuters - Tue, Aug 7, 2012

      * Animal experiments show gene therapy can boost performance * Gene doping likely to be dangerous and risky in humans * Tests can't detect it, so status of gene doping … More »FEATURE-Testers fear reality of genetically modified Olympians

      * Animal experiments show gene therapy can boost performance * Gene doping likely to be dangerous and risky in humans * Tests can't detect it, so status of gene doping unclear LONDON, Aug 7 (Reuters) - There have been "marathon mice","Schwarzenegger mice" and dogs whose wasted muscles wererepaired with injected substances …

    • Genetic study offers clues to history of North Africa's Jews Sharon Begley - Reuters - Mon, Aug 6, 2012

      NEW YORK (Reuters) - A new genetic analysis has reconstructed the history of North Africa's Jews, showing that these populations date to biblical-era Israel and are not … More »Genetic study offers clues to history of North Africa's Jews

      NEW YORK (Reuters) - A new genetic analysis has reconstructed the history of North Africa's Jews, showing that these populations date to biblical-era Israel and are not largely the descendants of natives who converted to Judaism, scientists reported on Monday. The study also shows that these Jews form two distinct groups, …

    • Pluristem stem cells save second patient with bone marrow failure Reuters - Mon, Aug 6, 2012

      TEL AVIV (Reuters) - Pluristem Therapeutics said another patient suffering from bone marrow failure was saved using its placenta-based stem cell treatment. This is the … More »Pluristem stem cells save second patient with bone marrow failure

      TEL AVIV (Reuters) - Pluristem Therapeutics said another patient suffering from bone marrow failure was saved using its placenta-based stem cell treatment. This is the second time in three months that a patient suffering from bone marrow failure was successfully treated with its PLX cells, the Israeli company said on Monday. …

    • Cancer debate: Are tumors fueled by stem cells? MALCOLM RITTER - AP - Wed, Aug 1, 2012

      Scientists have found new evidence for a theory about why some cancers return after they've seemingly been wiped out. Three studies in mice say tumors contain a pool … More »Cancer debate: Are tumors fueled by stem cells?

      Scientists have found new evidence for a theory about why some cancers return after they've seemingly been wiped out. Three studies in mice say tumors contain a pool of cancer stem cells that can multiply and seed the tumor's regrowth.

    • Evidence Grows That Cancer Has Its Own Stem Cells By Lisa Esposito
      HealthDay Reporter - HealthDay - Wed, Aug 1, 2012

      WEDNESDAY, Aug. 1 (HealthDay News) -- While scientists hotly debate the existence of cancer stem cells, three related new studies, all conducted on mice, provide some … More »Evidence Grows That Cancer Has Its Own Stem Cells

      WEDNESDAY, Aug. 1 (HealthDay News) -- While scientists hotly debate the existence of cancer stem cells, three related new studies, all conducted on mice, provide some supporting evidence.

    • Stem cells are viewed on a computer screen
      Stem cells blamed for cancer re-growth Mariette le Roux - AFP - Wed, Aug 1, 2012

      Researchers presented evidence Wednesday for the existence of cancer stem cells, with three different studies seeking to end a decades-old scientific dispute about how … More »Stem cells blamed for cancer re-growth

      Stem cells are viewed on a computer screen

      Researchers presented evidence Wednesday for the existence of cancer stem cells, with three different studies seeking to end a decades-old scientific dispute about how tumours grow.

    • Scientists ID New Gene Linked to Vision Loss in Infants HealthDay - Tue, Jul 31, 2012

      MONDAY, July 30 (HealthDay News) -- A new gene associated with a rare form of blindness from birth has been identified by researchers. More »Scientists ID New Gene Linked to Vision Loss in Infants

      MONDAY, July 30 (HealthDay News) -- A new gene associated with a rare form of blindness from birth has been identified by researchers.

    • Scientists Uncover Gene Variation Linked to Melanoma HealthDay - Tue, Jul 31, 2012

      SUNDAY, July 29 (HealthDay News) -- New gene mutations associated with the development of melanoma have been identified by scientists who conducted what is believed to … More »Scientists Uncover Gene Variation Linked to Melanoma

      SUNDAY, July 29 (HealthDay News) -- New gene mutations associated with the development of melanoma have been identified by scientists who conducted what is believed to be the largest DNA-sequencing study of the deadly disease to date.

    • Could Gene Doping Be Part of Future Olympics? Maureen Salamon
      HealthDay Reporter - HealthDay - Sat, Jul 28, 2012

      THURSDAY, July 26 (HealthDay News) -- Despite all the training, sweat, dedication and sacrifice that goes into becoming an Olympic competitor, these elite athletes also … More »Could Gene Doping Be Part of Future Olympics?

      THURSDAY, July 26 (HealthDay News) -- Despite all the training, sweat, dedication and sacrifice that goes into becoming an Olympic competitor, these elite athletes also tend to have an advantage that average sports lovers lack: superior DNA. Just like eye color or a keen intellect, a constellation of the "right" genes can …

    • Teen Doing Well 2 Years After Stem Cell Windpipe Transplant HealthDay - Fri, Jul 27, 2012

      WEDNESDAY, July 25 (HealthDay News) -- Two years after he became the first child to receive a stem cell-supported trachea (windpipe) transplant, a 13-year-old boy is … More »Teen Doing Well 2 Years After Stem Cell Windpipe Transplant

      WEDNESDAY, July 25 (HealthDay News) -- Two years after he became the first child to receive a stem cell-supported trachea (windpipe) transplant, a 13-year-old boy is able to breathe normally, has grown about four inches taller, does not require any anti-rejection drugs and has returned to school.

    • Genetic Technologies gets nod to sell cancer test in California Reuters - Thu, Jul 26, 2012

      (Reuters) - Genetic Technologies Ltd said its lead cancer test BrevaGen has been cleared for sale in California, which it expects to be a large and significant market. … More »Genetic Technologies gets nod to sell cancer test in California

      (Reuters) - Genetic Technologies Ltd said its lead cancer test BrevaGen has been cleared for sale in California, which it expects to be a large and significant market. The Nasdaq-listed shares of the company, which has operations in Australia and the United States, rose as much as 37 percent to $4.79 on Thursday morning, …

    • Stem Cells Show Promise as Heart Failure Treatment HealthDay - Mon, Jul 23, 2012

      MONDAY, July 23 (HealthDay News) -- Scientists who used modified stem cells to rejuvenate damaged and aged heart cells from elderly heart failure patients say their research … More »Stem Cells Show Promise as Heart Failure Treatment

      MONDAY, July 23 (HealthDay News) -- Scientists who used modified stem cells to rejuvenate damaged and aged heart cells from elderly heart failure patients say their research could one day lead to new treatments for the illness.

    • Israel adult stem cell trials - hope for ALS patients? Tova Cohen - Reuters - Mon, Jul 23, 2012

      TEL AVIV (Reuters) - A clinical trial of ALS patients conducted by BrainStorm Cell Therapeutics shows its adult stem cell therapy is well-tolerated, appears to be safe … More »Israel adult stem cell trials - hope for ALS patients?

      TEL AVIV (Reuters) - A clinical trial of ALS patients conducted by BrainStorm Cell Therapeutics shows its adult stem cell therapy is well-tolerated, appears to be safe and does not present undue risk, according to an interim safety review. Moreover, in some patients signs of stabilization of the disease were detected. Israel-based …

    • U.S. appeals court reconsiders Myriad gene patent ruling Drew Singer - Reuters - Fri, Jul 20, 2012

      WASHINGTON (Reuters) - Myriad Genetics Inc illegally patented acts of nature when it claimed ownership of two genes linked to cancer, the federal government told an appeals … More »U.S. appeals court reconsiders Myriad gene patent ruling

      WASHINGTON (Reuters) - Myriad Genetics Inc illegally patented acts of nature when it claimed ownership of two genes linked to cancer, the federal government told an appeals court on Friday. Lawyers from Myriad, as well as the American Civil Liberties Union and the U.S. Patent and Trademark Office appeared in the U.S. Court …

    • European regulator: Gene therapy treatment OK MARIA CHENG - AP - Fri, Jul 20, 2012

      The European Medicines Agency is recommending the first-ever approval of a gene therapy treatment in the EU, in a significant move for a type of treatment that has so … More »European regulator: Gene therapy treatment OK

      The European Medicines Agency is recommending the first-ever approval of a gene therapy treatment in the EU, in a significant move for a type of treatment that has so far failed to deliver on its promise to cure diseases.

    • A gene therapy illustration courtesy of UniQure
      European regulators back first gene therapy drug Ben Hirschler - Reuters - Fri, Jul 20, 2012

      LONDON (Reuters) - European regulators have recommended approval of the Western world's first gene therapy drug -- after rejecting it on three previous occasions -- in … More »European regulators back first gene therapy drug

      A gene therapy illustration courtesy of UniQure

      LONDON (Reuters) - European regulators have recommended approval of the Western world's first gene therapy drug -- after rejecting it on three previous occasions -- in a significant advance for the novel medical technology. More than 20 years since the first experiments with the ground-breaking method for fixing faulty …

    • The Human Genome Sciences Laboratories and Offices building is seen in Rockville, Maryland
      Surge in biotech deals to unlock big investor profits Paritosh Bansal, Soyoung Kim and Sam Forgione - Reuters - Wed, Jul 18, 2012

      NEW YORK (Reuters) - Large investors in U.S. biotech companies are likely to capture serious windfall profits as deal activity picks up in the sector. A Reuters analysis … More »Surge in biotech deals to unlock big investor profits

      The Human Genome Sciences Laboratories and Offices building is seen in Rockville, Maryland

      NEW YORK (Reuters) - Large investors in U.S. biotech companies are likely to capture serious windfall profits as deal activity picks up in the sector. A Reuters analysis of investors' average cost found that six U.S. biotech companies flagged as potential takeover targets could yield billions of dollars in profits for their …

    • The Human Genome Sciences Laboratories and Offices building is seen in Rockville, Maryland
      Dealtalk: Surge in biotech deals to unlock big investor profits Paritosh Bansal, Soyoung Kim and Sam Forgione - Reuters - Wed, Jul 18, 2012

      NEW YORK (Reuters) - Large investors in U.S. biotech companies are likely to capture serious windfall profits as deal activity picks up in the sector. A Reuters analysis … More »Dealtalk: Surge in biotech deals to unlock big investor profits

      The Human Genome Sciences Laboratories and Offices building is seen in Rockville, Maryland

      NEW YORK (Reuters) - Large investors in U.S. biotech companies are likely to capture serious windfall profits as deal activity picks up in the sector. A Reuters analysis of investors' average cost found that six U.S. biotech companies flagged as potential takeover targets could yield billions of dollars in profits for their …

    • National Institutes of Health Director Francis Collins
      Gene scans show colon, rectal tumours are same AFP - Wed, Jul 18, 2012

      The biggest genetic analysis of colon and rectal tumours show that these cancer types are almost indistinguishable, a finding that could improve treatment options, a … More »Gene scans show colon, rectal tumours are same

      National Institutes of Health Director Francis Collins

      The biggest genetic analysis of colon and rectal tumours show that these cancer types are almost indistinguishable, a finding that could improve treatment options, a study said on Wednesday.

    • New Chief Executive of GlaxoSmithKline Witty poses for photographers outside the company headquarters in west London
      Analysis: GSK bolsters medicine chest with biotechnology buy Ben Hirschler - Reuters - Mon, Jul 16, 2012

      LONDON (Reuters) - GlaxoSmithKline chief executive Andrew Witty has an eye for a bargain. Despite paying a 99 percent premium for Human Genome Sciences, he is still getting … More »Analysis: GSK bolsters medicine chest with biotechnology buy

      New Chief Executive of GlaxoSmithKline Witty poses for photographers outside the company headquarters in west London

      LONDON (Reuters) - GlaxoSmithKline chief executive Andrew Witty has an eye for a bargain. Despite paying a 99 percent premium for Human Genome Sciences, he is still getting the biotechnology company for less than half what it was worth 14 months ago. In exchange for his $3 billion cheque, which GSK can pay out of existing …

     

    Subscribe

    [X]

    How to subscribe

    Roll over each section to subscribe using Add to My Yahoo! or RSS Feed feeds.

    Yahoo! News offers dozens of RSS feeds you can read in My Yahoo! or using third-party RSS news reader software. Click here to find out more about RSS and how you can use it with Yahoo! News.